BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25633829)

  • 41. Evaluation of a side population of canine lymphoma cells using Hoechst 33342 dye.
    Kim MC; D'Costa S; Suter S; Kim Y
    J Vet Sci; 2013; 14(4):481-6. PubMed ID: 23820219
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Identification and characterization of stem cells in an ovarian cancer cell line and examination their drug resistance].
    Wei Z; Wang Y; Yu X; Zhang S
    Zhonghua Fu Chan Ke Za Zhi; 2015 Jun; 50(6):452-7. PubMed ID: 26311554
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oncogene-specific formation of chemoresistant murine hepatic cancer stem cells.
    Chow EK; Fan LL; Chen X; Bishop JM
    Hepatology; 2012 Oct; 56(4):1331-41. PubMed ID: 22505225
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumorigenic lung tumorospheres exhibit stem-like features with significantly increased expression of CD133 and ABCG2.
    Zhao W; Luo Y; Li B; Zhang T
    Mol Med Rep; 2016 Sep; 14(3):2598-606. PubMed ID: 27432082
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Isolation and phenotypic characterization of cancer stem like cells from nasopharyngeal carcinoma.
    Wang Y; Zhang GH; Li SL
    Drug Res (Stuttg); 2015 Jun; 65(6):323-6. PubMed ID: 25207708
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lung cancer stem cells: The root of resistance.
    MacDonagh L; Gray SG; Breen E; Cuffe S; Finn SP; O'Byrne KJ; Barr MP
    Cancer Lett; 2016 Mar; 372(2):147-56. PubMed ID: 26797015
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical implications of cancer stem cell-like side population cells in human laryngeal cancer.
    Yu D; Jin C; Liu Y; Yang J; Zhao Y; Wang H; Zhao X; Cheng J; Liu X; Liu C
    Tumour Biol; 2013 Dec; 34(6):3603-10. PubMed ID: 23807678
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolation of Cancer Stem Cells by Side Population Method.
    Shimoda M; Ota M; Okada Y
    Methods Mol Biol; 2018; 1692():49-59. PubMed ID: 28986886
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Breast cancer, side population cells and ABCG2 expression.
    Britton KM; Eyre R; Harvey IJ; Stemke-Hale K; Browell D; Lennard TWJ; Meeson AP
    Cancer Lett; 2012 Oct; 323(1):97-105. PubMed ID: 22521545
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The side population of gliomas exhibits decreased cell migration.
    Weber K; Paulus W; Senner V
    J Neuropathol Exp Neurol; 2010 Jun; 69(6):623-31. PubMed ID: 20467330
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isolation, identification, and characterization of cancer stem cells: A review.
    Abbaszadegan MR; Bagheri V; Razavi MS; Momtazi AA; Sahebkar A; Gholamin M
    J Cell Physiol; 2017 Aug; 232(8):2008-2018. PubMed ID: 28019667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sodium butyrate inhibits the self-renewal capacity of endometrial tumor side-population cells by inducing a DNA damage response.
    Kato K; Kuhara A; Yoneda T; Inoue T; Takao T; Ohgami T; Dan L; Kuboyama A; Kusunoki S; Takeda S; Wake N
    Mol Cancer Ther; 2011 Aug; 10(8):1430-9. PubMed ID: 21632462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reversing paclitaxel resistance in ovarian cancer cells via inhibition of the ABCB1 expressing side population.
    Eyre R; Harvey I; Stemke-Hale K; Lennard TW; Tyson-Capper A; Meeson AP
    Tumour Biol; 2014 Oct; 35(10):9879-92. PubMed ID: 24993095
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elimination of stem-like cancer cell side-population by auranofin through modulation of ROS and glycolysis.
    Hou GX; Liu PP; Zhang S; Yang M; Liao J; Yang J; Hu Y; Jiang WQ; Wen S; Huang P
    Cell Death Dis; 2018 Jan; 9(2):89. PubMed ID: 29367724
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug screening identifies niclosamide as an inhibitor of breast cancer stem-like cells.
    Wang YC; Chao TK; Chang CC; Yo YT; Yu MH; Lai HC
    PLoS One; 2013; 8(9):e74538. PubMed ID: 24058587
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of voltage-gated potassium channels attenuates resistance of side-population cells to gefitinib in the human lung cancer cell line NCI-H460.
    Choi SY; Kim HR; Ryu PD; Lee SY
    BMC Pharmacol Toxicol; 2017 Feb; 18(1):14. PubMed ID: 28219421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dexamethasone reduces side population fraction through downregulation of ABCG2 transporter in MCF-7 breast cancer cells.
    Kim JB; Hwang SE; Yoon SP
    Mol Med Rep; 2017 Jul; 16(1):453-458. PubMed ID: 28498438
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Harnessing the DNA Dye-triggered Side Population Phenotype to Detect and Purify Cancer Stem Cells from Biological Samples.
    Boesch M; Hoflehner E; Wolf D; Gastl G; Sopper S
    J Vis Exp; 2017 May; (123):. PubMed ID: 28518118
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Significance of ATP-binding cassette transporter proteins in multidrug resistance of head and neck squamous cell carcinoma.
    Guan GF; Zhang DJ; Zheng Y; Wen LJ; Yu DJ; Lu YQ; Zhao Y
    Oncol Lett; 2015 Aug; 10(2):631-636. PubMed ID: 26622545
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bortezomib Is More Effective to Side Population of RPMI8226 Myeloma Cells than Classical Anti-myeloma Agents.
    Kim KH; Cheong HJ; Lee MY; Lee N; Lee KT; Park SK; Won JH
    Anticancer Res; 2019 Jan; 39(1):127-133. PubMed ID: 30591449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.